Download PDF
Semin Respir Crit Care Med 2017; 38(04): 514-522
DOI: 10.1055/s-0037-1602382
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Ocular Involvement in Sarcoidosis

Fahriye Groen
1   Department of Ophthalmology, Erasmus Medical Center, Erasmus University, Rotterdam, The Netherlands
,
Aniki Rothova
1   Department of Ophthalmology, Erasmus Medical Center, Erasmus University, Rotterdam, The Netherlands
› Author Affiliations
Further Information

Publication History

Publication Date:
27 July 2017 (online)

    Permissions and Reprints

Abstract

Ocular involvement in sarcoidosis occurs in ∼40% and the eye is the presenting organ in roughly 20%. The course of ocular disease does not necessarily parallel that of systemic disease. Uveitis is the most common presentation and shows mainly a chronic course; anterior uveitis is associated with better visual prognosis than posterior localization. Painful bilateral anterior granulomatous uveitis most commonly occurs in black patients at younger age, while painless posterior bilateral involvement with peripheral multifocal choroiditis is commonly seen in elderly white females. Patients with posterior uveitis develop often ocular complications and central nervous system involvement. Vitritis, segmental periphlebitis, choroidal granulomas, and peripheral multifocal chorioretinitis are often seen clinical features. Optic nerve involvement is uncommon, but if present, results often in poor visual outcome. Lacrimal gland and conjunctival involvement are also common and present clinically as dry eyes or remain asymptomatic with good visual prognosis. Sarcoidosis-associated uveitis is mostly managed by local treatment with steroid drops or periocular and intraocular steroid injections or with novel intraocular corticosteroid implants. Patients with sight-threatening disease or optic nerve involvement need systemic therapy. Systemic therapy is based on a step-up regimen where corticosteroids are used in the initial phase of the disease and if long-term treatment is required, steroid-sparing immunomodulatory drugs are implemented such as methotrexate or biological agents. Despite the mainly chronic course, need for long-term treatment, and frequent ocular surgeries in the majority of patients, the visual outcome of sarcoidosis-associated uveitis is fairly good if therapy has started on time.

Keywords

sarcoidosis - ocular sarcoidosis - sarcoidosis-associated uveitis - lacrimal gland involvement - treatment ocular sarcoidosis - diagnosis of ocular sarcoidosis
 

  • References

  • 1 Doyle AC. The Complete Sherlock Holmes. New York: Doubleday & Company; 1930
    Google Scholar
  • 2 Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 1996; 80 (04) 332-336
    CrossrefPubMedGoogle Scholar
  • 3 Jabs DA, Johns CJ. Ocular involvement in chronic sarcoidosis. Am J Ophthalmol 1986; 102 (03) 297-301
    CrossrefPubMedGoogle Scholar
  • 4 Kirsch O, Frau E, Nodarian M, Labetoulle M, Offret H. Clinical course of ocular sarcoidosis in patients with histologically proven systemic sarcoidosis[in French]. J Fr Ophtalmol 2001; 24 (06) 623-627
    PubMedGoogle Scholar
  • 5 Hassenstein A, Bialasiewicz AA, Knospe V, Richard G. Incidence of ocular manifestations in patients with histologically confirmed systemic sarcoidosis [in German]. Klin Monatsbl Augenheilkd 2003; 220 (06) 414-417
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Rothova A, Alberts C, Glasius E, Kijlstra A, Buitenhuis HJ, Breebaart AC. Risk factors for ocular sarcoidosis. Doc Ophthalmol 1989; 72 (3-4): 287-296
    CrossrefPubMedGoogle Scholar
  • 7 Siltzbach LE, James DG, Neville E. , et al. Course and prognosis of sarcoidosis around the world. Am J Med 1974; 57 (06) 847-852
    CrossrefPubMedGoogle Scholar
  • 8 James DG, Anderson R, Langley D, Ainslie D. Ocular sarcoidosis. Br J Ophthalmol 1964; 48: 461-470
    CrossrefPubMedGoogle Scholar
  • 9 James DG, Neville E, Siltzbach LE. A worldwide review of sarcoidosis. Ann N Y Acad Sci 1976; 278: 321-334
    CrossrefPubMedGoogle Scholar
  • 10 Demirci H, Christianson MD. Orbital and adnexal involvement in sarcoidosis: analysis of clinical features and systemic disease in 30 cases. Am J Ophthalmol 2011; 151 (06) 1074-1080.e1
    CrossrefPubMedGoogle Scholar
  • 11 Heiligenhaus A, Wefelmeyer D, Wefelmeyer E, Rösel M, Schrenk M. The eye as a common site for the early clinical manifestation of sarcoidosis. Ophthalmic Res 2011; 46 (01) 9-12
    CrossrefPubMedGoogle Scholar
  • 12 Febvay C, Kodjikian L, Maucort-Boulch D. , et al. Clinical features and diagnostic evaluation of 83 biopsy-proven sarcoid uveitis cases. Br J Ophthalmol 2015; 99 (10) 1372-1376
    CrossrefPubMedGoogle Scholar
  • 13 Atmaca LS, Atmaca-Sönmez P, Idil A, Kumbasar OO, Celik G. Ocular involvement in sarcoidosis. Ocul Immunol Inflamm 2009; 17 (02) 91-94
    CrossrefPubMedGoogle Scholar
  • 14 Baughman RP, Teirstein AS, Judson MA. , et al; A Case Control Etiologic Study of Sarcoidosis (ACCESS) research group. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001; 164 (10 Pt 1): 1885-1889
    CrossrefPubMedGoogle Scholar
  • 15 Morimoto T, Azuma A, Abe S. , et al. Epidemiology of sarcoidosis in Japan. Eur Respir J 2008; 31 (02) 372-379
    CrossrefPubMedGoogle Scholar
  • 16 Pietinalho A, Ohmichi M, Hiraga Y, Löfroos AB, Selroos O. The mode of presentation of sarcoidosis in Finland and Hokkaido, Japan. A comparative analysis of 571 Finnish and 686 Japanese patients. Sarcoidosis Vasc Diffuse Lung Dis 1996; 13 (02) 159-166
    PubMedGoogle Scholar
  • 17 Ohara K, Okubo A, Sasaki H, Kamata K. Intraocular manifestations of systemic sarcoidosis. Jpn J Ophthalmol 1992; 36 (04) 452-457
    PubMedGoogle Scholar
  • 18 Iwata K, Nanba K, Sobue K, Abe H. Ocular sarcoidosis: evaluation of intraocular findings. Ann N Y Acad Sci 1976; 278: 445-454
    CrossrefPubMedGoogle Scholar
  • 19 Mizuno K, Takahashi J. Sarcoid cyclitis. Ophthalmology 1986; 93 (04) 511-517
    CrossrefPubMedGoogle Scholar
  • 20 Pietinalho A, Ohmichi M, Löfroos AB, Hiraga Y, Selroos O. The prognosis of pulmonary sarcoidosis in Finland and Hokkaido, Japan. A comparative five-year study of biopsy-proven cases. Sarcoidosis Vasc Diffuse Lung Dis 2000; 17 (02) 158-166
    PubMedGoogle Scholar
  • 21 Nakagawa YMK, Mimura Y, Yuasa T. Ophthalmological observation of sarcoidosis. Nihon Ganpa Kiyo (Folia Ophthalmolgica Japonica) 1978; 29: 2009-2012
    PubMedGoogle Scholar
  • 22 Uyama MOM, Asayama K, Hyashi M, Okinami S, Ueno S. Clinical pictures of sarcoid uveitis. Nihon Ganpa Kiyo (Folia Ophthalmolgica Japonica) 1976; 27: 170-177
    PubMedGoogle Scholar
  • 23 Llorenç V, Mesquida M, Sainz de la Maza M. , et al. Epidemiology of uveitis in a Western urban multiethnic population. The challenge of globalization. Acta Ophthalmol 2015; 93 (06) 561-567
    CrossrefPubMedGoogle Scholar
  • 24 Chebil A, Baroudi B, Slim M. , et al. Epidemiology of uveitis in the Tunis area [in French]. J Fr Ophtalmol 2013; 36 (09) 764-768
    CrossrefPubMedGoogle Scholar
  • 25 Jakob E, Reuland MS, Mackensen F. , et al. Uveitis subtypes in a german interdisciplinary uveitis center--analysis of 1916 patients. J Rheumatol 2009; 36 (01) 127-136
    CrossrefPubMedGoogle Scholar
  • 26 Goto H, Mochizuki M, Yamaki K, Kotake S, Usui M, Ohno S. Epidemiological survey of intraocular inflammation in Japan. Jpn J Ophthalmol 2007; 51 (01) 41-44
    CrossrefPubMedGoogle Scholar
  • 27 Tsirouki T, Dastiridou A, Symeonidis C. , et al. A focus on the epidemiology of uveitis. Ocul Immunol Inflamm 2016; DOI: 10.1080/09273948.2016.1196713.
    CrossrefPubMedGoogle Scholar
  • 28 Wakabayashi T, Morimura Y, Miyamoto Y, Okada AA. Changing patterns of intraocular inflammatory disease in Japan. Ocul Immunol Inflamm 2003; 11 (04) 277-286
    CrossrefPubMedGoogle Scholar
  • 29 Das D, Bhattacharjee H, Bhattacharyya PK. , et al. Pattern of uveitis in north east India: a tertiary eye care center study. Indian J Ophthalmol 2009; 57 (02) 144-146
    CrossrefPubMedGoogle Scholar
  • 30 Çakar Özdal MP, Yazici A, Tüfek M, Öztürk F. Epidemiology of uveitis in a referral hospital in Turkey. Turk J Med Sci 2014; 44 (02) 337-342
    CrossrefPubMedGoogle Scholar
  • 31 Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160 (02) 736-755
    CrossrefPubMedGoogle Scholar
  • 32 Krell W, Bourbonnais JM, Kapoor R, Samavati L. Effect of smoking and gender on pulmonary function and clinical features in sarcoidosis. Lung 2012; 190 (05) 529-536
    CrossrefPubMedGoogle Scholar
  • 33 Ungprasert P, Crowson CS, Matteson EL. Influence of gender on epidemiology and clinical manifestations of sarcoidosis: a population-based retrospective cohort study 1976-2013. Lung 2017; 195 (01) 87-91
    CrossrefPubMedGoogle Scholar
  • 34 Rothova A. Ocular involvement in sarcoidosis. Br J Ophthalmol 2000; 84 (01) 110-116
    CrossrefPubMedGoogle Scholar
  • 35 Evans M, Sharma O, LaBree L, Smith RE, Rao NA. Differences in clinical findings between Caucasians and African Americans with biopsy-proven sarcoidosis. Ophthalmology 2007; 114 (02) 325-333
    CrossrefPubMedGoogle Scholar
  • 36 Chung YM, Lin YC, Liu YT, Chang SC, Liu HN, Hsu WH. Uveitis with biopsy-proven sarcoidosis in Chinese--a study of 60 patients in a uveitis clinic over a period of 20 years. J Chin Med Assoc 2007; 70 (11) 492-496
    CrossrefPubMedGoogle Scholar
  • 37 Henke CE, Henke G, Elveback LR, Beard CM, Ballard DJ, Kurland LT. The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival. Am J Epidemiol 1986; 123 (05) 840-845
    CrossrefPubMedGoogle Scholar
  • 38 Rybicki BA, Major M, Popovich Jr J, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997; 145 (03) 234-241
    CrossrefPubMedGoogle Scholar
  • 39 Bresnitz EA, Strom BL. Epidemiology of sarcoidosis. Epidemiol Rev 1983; 5: 124-156
    CrossrefPubMedGoogle Scholar
  • 40 Reich JM. Course and prognosis of sarcoidosis in African-Americans versus Caucasians. Eur Respir J 2001; 17 (04) 833
    CrossrefPubMedGoogle Scholar
  • 41 Choudhary MM, Hajj-Ali RA, Lowder CY. Gender and ocular manifestations of connective tissue diseases and systemic vasculitides. J Ophthalmol 2014; 2014: 403042
    PubMedGoogle Scholar
  • 42 Judson MA, Boan AD, Lackland DT. The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. Sarcoidosis Vasc Diffuse Lung Dis 2012; 29 (02) 119-127
    PubMedGoogle Scholar
  • 43 Dana MR, Merayo-Lloves J, Schaumberg DA, Foster CS. Prognosticators for visual outcome in sarcoid uveitis. Ophthalmology 1996; 103 (11) 1846-1853
    CrossrefPubMedGoogle Scholar
  • 44 Birnbaum AD, Oh FS, Chakrabarti A, Tessler HH, Goldstein DA. Clinical features and diagnostic evaluation of biopsy-proven ocular sarcoidosis. Arch Ophthalmol 2011; 129 (04) 409-413
    CrossrefPubMedGoogle Scholar
  • 45 Birnbaum AD, French DD, Mirsaeidi M, Wehrli S. Sarcoidosis in the national veteran population: association of ocular inflammation and mortality. Ophthalmology 2015; 122 (05) 934-938
    CrossrefPubMedGoogle Scholar
  • 46 Smith JA, Foster CS. Sarcoidosis and its ocular manifestations. Int Ophthalmol Clin 1996; 36 (01) 109-125
    PubMedGoogle Scholar
  • 47 Crick RP, Hoyle C, Smellie H. The eyes in sarcoidosis. Br J Ophthalmol 1961; 45 (07) 461-481
    CrossrefPubMedGoogle Scholar
  • 48 Spalton DJ, Sanders MD. Fundus changes in histologically confirmed sarcoidosis. Br J Ophthalmol 1981; 65 (05) 348-358
    CrossrefPubMedGoogle Scholar
  • 49 Wolfensberger TJ, Herbort CP. Indocyanine green angiographic features in ocular sarcoidosis. Ophthalmology 1999; 106 (02) 285-289
    CrossrefPubMedGoogle Scholar
  • 50 Desai UR, Tawansy KA, Joondeph BC, Schiffman RM. Choroidal granulomas in systemic sarcoidosis. Retina 2001; 21 (01) 40-47
    CrossrefPubMedGoogle Scholar
  • 51 Khalatbari D, Stinnett S, McCallum RM, Jaffe GJ. Demographic-related variations in posterior segment ocular sarcoidosis. Ophthalmology 2004; 111 (02) 357-362
    CrossrefPubMedGoogle Scholar
  • 52 Kay DJ, Saffra N, Har-El G. Isolated sarcoidosis of the lacrimal sac without systemic manifestations. Am J Otolaryngol 2002; 23 (01) 53-55
    CrossrefPubMedGoogle Scholar
  • 53 Costabel U, Hunninghake GW. ; Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. ATS/ERS/WASOG statement on sarcoidosis. Eur Respir J 1999; 14 (04) 735-737
    CrossrefPubMedGoogle Scholar
  • 54 Hillerdal G, Nöu E, Osterman K, Schmekel B. Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis 1984; 130 (01) 29-32
    PubMedGoogle Scholar
  • 55 Varron L, Cottin V, Schott AM, Broussolle C, Sève P. Late-onset sarcoidosis: a comparative study. Medicine (Baltimore) 2012; 91 (03) 137-143
    CrossrefPubMedGoogle Scholar
  • 56 Nagata K, Maruyama K, Sugita S. , et al. Age differences in sarcoidosis patients with posterior ocular lesions. Ocul Immunol Inflamm 2014; 22 (04) 257-262
    CrossrefPubMedGoogle Scholar
  • 57 Herbort CP, Rao NA, Mochizuki M. ; members of Scientific Committee of First International Workshop on Ocular Sarcoidosis. International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop on Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm 2009; 17 (03) 160-169
    CrossrefPubMedGoogle Scholar
  • 58 Weinreb RN, Sandman R, Ryder MI, Friberg TR. Angiotensin-converting enzyme activity in human aqueous humor. Arch Ophthalmol 1985; 103 (01) 34-36
    CrossrefPubMedGoogle Scholar
  • 59 Cowan Jr CL. Review for disease of the year: differential diagnosis of ocular sarcoidosis. Ocul Immunol Inflamm 2010; 18 (06) 442-451
    CrossrefPubMedGoogle Scholar
  • 60 Obenauf CD, Shaw HE, Sydnor CF, Klintworth GK. Sarcoidosis and its ophthalmic manifestations. Am J Ophthalmol 1978; 86 (05) 648-655
    CrossrefPubMedGoogle Scholar
  • 61 Agrawal RV, Murthy S, Sangwan V, Biswas J. Current approach in diagnosis and management of anterior uveitis. Indian J Ophthalmol 2010; 58 (01) 11-19
    CrossrefPubMedGoogle Scholar
  • 62 Pasadhika S, Rosenbaum JT. Ocular sarcoidosis. Clin Chest Med 2015; 36 (04) 669-683
    CrossrefPubMedGoogle Scholar
  • 63 Lobo A, Barton K, Minassian D, du Bois RM, Lightman S. Visual loss in sarcoid-related uveitis. Clin Experiment Ophthalmol 2003; 31 (04) 310-316
    CrossrefPubMedGoogle Scholar
  • 64 Derby GS. The nature of so-called Koeppe nodules. Trans Am Ophthalmol Soc 1928; 26: 62-71
    PubMedGoogle Scholar
  • 65 Fakin A, Terčelj M, Vidović Valentinčič N. Frequency of IWOS suggestive ocular signs in Slovenian uveitis patients with confirmed pulmonary sarcoidosis. Ocul Immunol Inflamm 2016; 24 (06) 660-664
    CrossrefPubMedGoogle Scholar
  • 66 Myers TD, Smith JR, Lauer AK, Rosenbaum JT. Iris nodules associated with infectious uveitis. Br J Ophthalmol 2002; 86 (09) 969-974
    CrossrefPubMedGoogle Scholar
  • 67 Zaidi AA, Ying GS, Daniel E. , et al; Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study. Hypopyon in patients with uveitis. Ophthalmology 2010; 117 (02) 366-372
    CrossrefPubMedGoogle Scholar
  • 68 Talat L, Lightman S, Tomkins-Netzer O. Ischemic retinal vasculitis and its management. J Ophthalmol 2014; 2014: 197675
    PubMedGoogle Scholar
  • 69 Abu El-Asrar AM, Herbort CP, Tabbara KF. Differential diagnosis of retinal vasculitis. Middle East Afr J Ophthalmol 2009; 16 (04) 202-218
    PubMedGoogle Scholar
  • 70 Gupta V, Gupta A, Rao NA. Intraocular tuberculosis--an update. Surv Ophthalmol 2007; 52 (06) 561-587
    CrossrefPubMedGoogle Scholar
  • 71 La Distia Nora R, van Velthoven ME, Ten Dam-van Loon NH. , et al. Clinical manifestations of patients with intraocular inflammation and positive QuantiFERON-TB gold in-tube test in a country nonendemic for tuberculosis. Am J Ophthalmol 2014; 157 (04) 754-761
    CrossrefPubMedGoogle Scholar
  • 72 Saleh MG, OʼDonnell JL, Davis RP, Wilson D, Lin P. Clinical pathologic correlation of sarcoidosis-associated multifocal chorioretinitis in an elderly patient. Retin Cases Brief Rep 2017; DOI: 10.1097/ICB.0000000000000547.
    CrossrefPubMedGoogle Scholar
  • 73 Ossewaarde-van Norel J, Ten Dam-van Loon N, de Boer JH, Rothova A. Long-term visual prognosis of peripheral multifocal chorioretinitis. Am J Ophthalmol 2015; 159 (04) 690-697
    CrossrefPubMedGoogle Scholar
  • 74 Lardenoye CW, Van der Lelij A, de Loos WS, Treffers WF, Rothova A. Peripheral multifocal chorioretinitis: a distinct clinical entity?. Ophthalmology 1997; 104 (11) 1820-1826
    CrossrefPubMedGoogle Scholar
  • 75 Stavrou P, Linton S, Young DW, Murray PI. Clinical diagnosis of ocular sarcoidosis. Eye (Lond) 1997; 11 (Pt 3): 365-370
    CrossrefPubMedGoogle Scholar
  • 76 Kosmorsky GS, Meisler DM, Rice TW, Meziane MA, Lowder CY. Chest computed tomography and mediastinoscopy in the diagnosis of sarcoidosis-associated uveitis. Am J Ophthalmol 1998; 126 (01) 132-134
    CrossrefPubMedGoogle Scholar
  • 77 Letocha CE, Shields JA, Goldberg RE. Retinal changes in sarcoidosis. Can J Ophthalmol 1975; 10 (02) 184-192
    PubMedGoogle Scholar
  • 78 Gould H, Kaufman HE. Sarcoid of the fundus. Arch Ophthalmol 1961; 65: 453-456
    CrossrefPubMedGoogle Scholar
  • 79 Frohman LP, Grigorian R, Bielory L. Neuro-ophthalmic manifestations of sarcoidosis: clinical spectrum, evaluation, and management. J Neuroophthalmol 2001; 21 (02) 132-137
    CrossrefPubMedGoogle Scholar
  • 80 Frohman LP, Guirgis M, Turbin RE, Bielory L. Sarcoidosis of the anterior visual pathway: 24 new cases. J Neuroophthalmol 2003; 23 (03) 190-197
    CrossrefPubMedGoogle Scholar
  • 81 Heuser K, Kerty E. Neuro-ophthalmological findings in sarcoidosis. Acta Ophthalmol Scand 2004; 82 (06) 723-729
    CrossrefPubMedGoogle Scholar
  • 82 Lamirel C, Badelon I, Gout O. , et al. Neuro-ophthalmologic initial presentation of sarcoidosis [in French]. J Fr Ophtalmol 2006; 29 (03) 241-249
    CrossrefPubMedGoogle Scholar
  • 83 Koczman JJ, Rouleau J, Gaunt M, Kardon RH, Wall M, Lee AG. Neuro-ophthalmic sarcoidosis: the University of Iowa experience. Semin Ophthalmol 2008; 23 (03) 157-168
    CrossrefPubMedGoogle Scholar
  • 84 Manz HJ. Pathobiology of neurosarcoidosis and clinicopathologic correlation. Can J Neurol Sci 1983; 10 (01) 50-55
    CrossrefPubMedGoogle Scholar
  • 85 Delaney P. Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases. Ann Intern Med 1977; 87 (03) 336-345
    CrossrefPubMedGoogle Scholar
  • 86 Ing EB, Garrity JA, Cross SA, Ebersold MJ. Sarcoid masquerading as optic nerve sheath meningioma. Mayo Clin Proc 1997; 72 (01) 38-43
    CrossrefPubMedGoogle Scholar
  • 87 Lower EE, Broderick JP, Brott TG, Baughman RP. Diagnosis and management of neurological sarcoidosis. Arch Intern Med 1997; 157 (16) 1864-1868
    CrossrefPubMedGoogle Scholar
  • 88 Fritz D, van de Beek D, Brouwer MC. Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis. BMC Neurol 2016; 16 (01) 220
    CrossrefPubMedGoogle Scholar
  • 89 Ricker W, Clark M. Sarcoidosis; a clinicopathologic review of 300 cases, including 22 autopsies. Am J Clin Pathol 1949; 19 (08) 725-749
    CrossrefPubMedGoogle Scholar
  • 90 Kelley JS, Green WR. Sarcoidosis involving the optic nerve head. Arch Ophthalmol 1973; 89 (06) 486-488
    CrossrefPubMedGoogle Scholar
  • 91 Beardsley TL, Brown SV, Sydnor CF, Grimson BS, Klintworth GK. Eleven cases of sarcoidosis of the optic nerve. Am J Ophthalmol 1984; 97 (01) 62-77
    CrossrefPubMedGoogle Scholar
  • 92 Zajicek JP, Scolding NJ, Foster O. , et al. Central nervous system sarcoidosis--diagnosis and management. QJM 1999; 92 (02) 103-117
    CrossrefPubMedGoogle Scholar
  • 93 Ostheimer TA, Burkholder BM, Leung TG, Butler NJ, Dunn JP, Thorne JE. Tattoo-associated uveitis. Am J Ophthalmol 2014; 158 (03) 637-43.e1
    CrossrefPubMedGoogle Scholar
  • 94 Rorsman H, Brehmer-Andersson E, Dahlquist I. , et al. Tattoo granuloma and uveitis. Lancet 1969; 2 (7610): 27-28
    PubMedGoogle Scholar
  • 95 Barabasi Z, Kiss E, Balaton G, Vajo Z. Cutaneous granuloma and uveitis caused by a tattoo. Wien Klin Wochenschr 2008; 120 (1-2): 18
    CrossrefPubMedGoogle Scholar
  • 96 Collison JM, Miller NR, Green WR. Involvement of orbital tissues by sarcoid. Am J Ophthalmol 1986; 102 (03) 302-307
    CrossrefPubMedGoogle Scholar
  • 97 Mavrikakis I, Rootman J. Diverse clinical presentations of orbital sarcoid. Am J Ophthalmol 2007; 144 (05) 769-775
    CrossrefPubMedGoogle Scholar
  • 98 Prabhakaran VC, Saeed P, Esmaeli B. , et al. Orbital and adnexal sarcoidosis. Arch Ophthalmol 2007; 125 (12) 1657-1662
    CrossrefPubMedGoogle Scholar
  • 99 Diestelmeier MR, Sausker WF, Pierson DL, Rodman OG. Sarcoidosis manifesting as eyelid swelling. Arch Dermatol 1982; 118 (05) 356-357
    CrossrefPubMedGoogle Scholar
  • 100 Jones BR, Stevenson CJ. Keratoconjunctivitis sicca due to sarcoidosis. Br J Ophthalmol 1957; 41 (03) 153-160
    CrossrefPubMedGoogle Scholar
  • 101 Chapman KL, Bartley GB, Garrity JA, Gonnering RS. Lacrimal bypass surgery in patients with sarcoidosis. Am J Ophthalmol 1999; 127 (04) 443-446
    CrossrefPubMedGoogle Scholar
  • 102 Heiligenhaus A, Wefelmeyer E, Schrenk M. Tear-film deficiencies in patients with sarcoidosis; clinical study of 56 patients [in German]. Klin Monatsbl Augenheilkd 2002; 219 (07) 502-506
    Article in Thieme ConnectPubMedGoogle Scholar
  • 103 Hall JG, Cohen KL. Sarcoidosis of the eyelid skin. Am J Ophthalmol 1995; 119 (01) 100-101
    CrossrefPubMedGoogle Scholar
  • 104 Rabinowitz MP, Halfpenny CP, Bedrossian Jr EH. The frequency of granulomatous lacrimal gland inflammation as a cause of lacrimal gland enlargement in patients without a diagnosis of systemic sarcoidosis. Orbit 2013; 32 (03) 151-155
    CrossrefPubMedGoogle Scholar
  • 105 Edelsten C, Pearson A, Joynes E, Stanford MR, Graham EM. The ocular and systemic prognosis of patients presenting with sarcoid uveitis. Eye (Lond) 1999; 13 (Pt 6): 748-753
    CrossrefPubMedGoogle Scholar
  • 106 Reynolds HY. Sarcoidosis: impact of other illnesses on the presentation and management of multi-organ disease. Lung 2002; 180 (05) 281-299
    CrossrefPubMedGoogle Scholar
  • 107 Rochepeau C, Jamilloux Y, Kerever S. , et al. Long-term visual and systemic prognoses of 83 cases of biopsy-proven sarcoid uveitis. Br J Ophthalmol 2016; DOI: 10.1136/bjophthalmol-2016-309767.
    CrossrefPubMedGoogle Scholar
  • 108 Radosavljević A, Jakšić V, Pezo L, Kovačević-Pavićević D, Ilić A, Mihailović Vučinić V. Clinical features of ocular sarcoidosis in patients with biopsy-proven pulmonary sarcoidosis in Serbia. Ocul Immunol Inflamm 2016; DOI: 10.3109/09273948.2016.1167224.
    CrossrefPubMedGoogle Scholar
  • 109 Sungur G, Hazirolan D, Bilgin G. Pattern of ocular findings in patients with biopsy-proven sarcoidosis in Turkey. Ocul Immunol Inflamm 2013; 21 (06) 455-461
    CrossrefPubMedGoogle Scholar
  • 110 Baughman RP, Lower EE, Kaufman AH. Ocular sarcoidosis. Semin Respir Crit Care Med 2010; 31 (04) 452-462
    Article in Thieme ConnectPubMedGoogle Scholar
  • 111 Baughman RP, Lower EE, Ingledue R, Kaufman AH. Management of ocular sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2012; 29 (01) 26-33
    PubMedGoogle Scholar
  • 112 de Boer JH, , B-SSHD, Erckens RJ. , et al. Richtlijn Uveitis. 2015
    PubMedGoogle Scholar
  • 113 Khurana RN, Porco TC. Efficacy and safety of dexamethasone intravitreal implant for persistent uveitic cystoid macular edema. Retina 2015; 35 (08) 1640-1646
    CrossrefPubMedGoogle Scholar
  • 114 Tomkins-Netzer O, Taylor SR, Bar A. , et al. Treatment with repeat dexamethasone implants results in long-term disease control in eyes with noninfectious uveitis. Ophthalmology 2014; 121 (08) 1649-1654
    CrossrefPubMedGoogle Scholar
  • 115 Pelegrín L, de la Maza MS, Molins B, Ríos J, Adán A. Long-term evaluation of dexamethasone intravitreal implant in vitrectomized and non-vitrectomized eyes with macular edema secondary to non-infectious uveitis. Eye (Lond) 2015; 29 (07) 943-950
    CrossrefPubMedGoogle Scholar
  • 116 Sugar EA, Holbrook JT, Kempen JH. , et al; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group. Cost-effectiveness of fluocinolone acetonide implant versus systemic therapy for noninfectious intermediate, posterior, and panuveitis. Ophthalmology 2014; 121 (10) 1855-1862
    CrossrefPubMedGoogle Scholar
  • 117 Jabs DA, Rosenbaum JT. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 2001; 131 (05) 679
    CrossrefPubMedGoogle Scholar
  • 118 Levy-Clarke G, Jabs DA, Read RW, Rosenbaum JT, Vitale A, Van Gelder RN. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. Ophthalmology 2014; 121 (03) 785-96.e3
    CrossrefPubMedGoogle Scholar
  • 119 Dev S, McCallum RM, Jaffe GJ. Methotrexate treatment for sarcoid-associated panuveitis. Ophthalmology 1999; 106 (01) 111-118
    CrossrefPubMedGoogle Scholar
  • 120 Shetty AK, Zganjar BE, Ellis Jr GS, Ludwig IH, Gedalia A. Low-dose methotrexate in the treatment of severe juvenile rheumatoid arthritis and sarcoid iritis. J Pediatr Ophthalmol Strabismus 1999; 36 (03) 125-128
    PubMedGoogle Scholar
  • 121 Samson CM, Waheed N, Baltatzis S, Foster CS. Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients. Ophthalmology 2001; 108 (06) 1134-1139
    CrossrefPubMedGoogle Scholar
  • 122 Maust HA, Foroozan R, Sergott RC, Niazi S, Weibel S, Savino PJ. Use of methotrexate in sarcoid-associated optic neuropathy. Ophthalmology 2003; 110 (03) 559-563
    CrossrefPubMedGoogle Scholar
  • 123 Gangaputra S, Newcomb CW, Liesegang TL. , et al; Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study. Methotrexate for ocular inflammatory diseases. Ophthalmology 2009; 116 (11) 2188-98.e1
    CrossrefPubMedGoogle Scholar
  • 124 Pasadhika S, Kempen JH, Newcomb CW. , et al. Azathioprine for ocular inflammatory diseases. Am J Ophthalmol 2009; 148 (04) 500-509.e2
    CrossrefPubMedGoogle Scholar
  • 125 Deuter CM, Doycheva D, Stuebiger N, Zierhut M. Mycophenolate sodium for immunosuppressive treatment in uveitis. Ocul Immunol Inflamm 2009; 17 (06) 415-419
    CrossrefPubMedGoogle Scholar
  • 126 Bhat P, Cervantes-Castañeda RA, Doctor PP, Anzaar F, Foster CS. Mycophenolate mofetil therapy for sarcoidosis-associated uveitis. Ocul Immunol Inflamm 2009; 17 (03) 185-190
    CrossrefPubMedGoogle Scholar
  • 127 Galor A, Jabs DA, Leder HA. , et al. Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation. Ophthalmology 2008; 115 (10) 1826-1832
    CrossrefPubMedGoogle Scholar
  • 128 Baughman RP, Lower EE, Bradley DA, Raymond LA, Kaufman A. Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trial. Chest 2005; 128 (02) 1062-47
    CrossrefPubMedGoogle Scholar
  • 129 Diaz-Llopis M, García-Delpech S, Salom D. , et al. Adalimumab therapy for refractory uveitis: a pilot study. J Ocul Pharmacol Ther 2008; 24 (03) 351-361
    CrossrefPubMedGoogle Scholar
  • 130 Baughman RP, Bradley DA, Lower EE. Infliximab in chronic ocular inflammation. Int J Clin Pharmacol Ther 2005; 43 (01) 7-11
    CrossrefPubMedGoogle Scholar
  • 131 Erckens RJ, Mostard RL, Wijnen PA, Schouten JS, Drent M. Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis. Graefes Arch Clin Exp Ophthalmol 2012; 250 (05) 713-720
    CrossrefPubMedGoogle Scholar
  • 132 Graves JE, Nunley K, Heffernan MP. Off-label uses of biologics in dermatology: rituximab, omalizumab, infliximab, etanercept, adalimumab, efalizumab, and alefacept (part 2 of 2). J Am Acad Dermatol 2007; 56 (01) e55-e79
    CrossrefPubMedGoogle Scholar
  • 133 Denys BG, Bogaerts Y, Coenegrachts KL, De Vriese AS. Steroid-resistant sarcoidosis: is antagonism of TNF-alpha the answer?. Clin Sci (Lond) 2007; 112 (05) 281-289
    CrossrefPubMedGoogle Scholar
  • 134 Fonollosa A, Artaraz J, Les I. , et al. Sarcoid intermediate uveitis following etanercept treatment: a case report and review of the literature. Ocul Immunol Inflamm 2012; 20 (01) 44-48
    CrossrefPubMedGoogle Scholar
  • 135 Suzuki J, Goto H. Uveitis associated with sarcoidosis exacerbated by etanercept therapy. Jpn J Ophthalmol 2009; 53 (04) 439-440
    CrossrefPubMedGoogle Scholar
  • 136 Hashkes PJ, Shajrawi I. Sarcoid-related uveitis occurring during etanercept therapy. Clin Exp Rheumatol 2003; 21 (05) 645-646
    PubMedGoogle Scholar
  • 137 Dragnev D, Barr D, Kulshrestha M, Shanmugalingam S. Sarcoid panuveitis associated with etanercept treatment, resolving with adalimumab. BMJ Case Rep 2013; 2013: pii: bcr2013200552
    PubMedGoogle Scholar
  • 138 Achille M, Ilaria P, Teresa G. , et al. Successful treatment with adalimumab for severe multifocal choroiditis and panuveitis in presumed (early-onset) ocular sarcoidosis. Int Ophthalmol 2016; 36 (01) 129-135
    CrossrefPubMedGoogle Scholar
  • 139 Seve P, Varron L, Broussolle C, Denis P, Kodjikian L. Sarcoid-related uveitis occurring during adalimumab therapy. Ocul Immunol Inflamm 2012; 20 (01) 59-60
    CrossrefPubMedGoogle Scholar
  • 140 Vallet H, Seve P, Biard L. , et al; French Uveitis Network. Infliximab Versus Adalimumab in the treatment of refractory inflammatory uveitis: a multicenter study from the French Uveitis Network. Arthritis Rheumatol 2016; 68 (06) 1522-1530
    CrossrefPubMedGoogle Scholar
  • 141 Miserocchi E, Modorati G, Di Matteo F, Galli L, Rama P, Bandello F. Visual outcome in ocular sarcoidosis: retrospective evaluation of risk factors. Eur J Ophthalmol 2011; 21 (06) 802-810
    CrossrefPubMedGoogle Scholar
  • 142 Steinkuller PG. Legal vision requirements for drivers in the United States. Virtual Mentor 2010; 12 (12) 938-940
    CrossrefPubMedGoogle Scholar
  • 143 Karma A, Huhti E, Poukkula A. Course and outcome of ocular sarcoidosis. Am J Ophthalmol 1988; 106 (04) 467-472
    CrossrefPubMedGoogle Scholar